Hemp-Derived CBD Products Dominate Cannabis Market With Escalating Revenues

Wednesday, October 24, 2018 General News
Email Print This Page Comment bookmark
Font : A-A+

PALM BEACH, Florida, October 24, 2018 /PRNewswire/ --

Financialnewsmedia.com News Commentary 

Just

as the legal cannabis industry has exploded in recent years, so too has a sector that revolves around the plant's non-psychoactive cousin: hemp-based cannabidiol (CBD). Hemp-derived CBD products continue to dominate the cannabis market as less legal
restrictions allow for companies to expand new products to previously untapped consumer segments. The demand for hemp-based cannabidiol has skyrocketed, especially since a 2013 CNN report about the success in Colorado of Charlotte's Web, a CBD product that helped a young epileptic girl control her seizures. CBD is expected to become a billion dollar industry itself and could potentially eclipse the entire traditional cannabis market, according to analysts. The Hemp Business Journal projects the industry will generate annual revenues north of $1 billion by 2020. Active Companies from around the market with current developments this week include: Marijuana Company of America, Inc. (OTC:MCOA), Medical Marijuana Inc. (OTC:MJNA), HEMP Inc. (OTC:HEMP), India Globalization Capital Inc. (NYSE:IGC), The Supreme Cannabis Company Inc. (TSX-V:FIRE) (OTC:SPRWF).

Marijuana Company of America, Inc. (OTCPK:MCOA) BREAKING NEWS: Marijuana Company of America, an innovative hemp and cannabis corporation, is pleased to announce that the Company's wholly-owned subsidiary hempSMART™ held its successful first South West Regional Event for its associates in Carlsbad, California on Monday October 22, 2018.

The event featured information regarding the Company's new platform rollout and compensation plan. The event also featured an in-depth discussion regarding product formulations and compliance which then concluded with instructions on how to start your own personal business, network, and how to maximize commissions for all hempSMART associates.

The all-day event gave associates the opportunity to meet and interact with the entire hempSMART staff including, CEO of MCOA, Donald Steinberg who discussed hempSMART's strategic global sales strategy moving forward and corporate strategy for the Company.

Donald Steinberg stated, "After months of hard work and development of our hempSMART brand I am proud to say that we have reached a tipping point. We have successfully launched the first of many regional events to be held across the country. Our CBD product brand (hempSMART) continues to grow rapidly and our Company looks forward to the international expansion of our brand in 2019."Read this and more news for MCOA at: http://www.financialnewsmedia.com/news-mcoa/

In the industry developments and happenings in the market this week include:    

Medical Marijuana Inc. (OTCPK:MJNA) announced on Tuesday that its subsidiary HempMeds® has garnered news coverage in leading international publication Men's Health. An Oct. 16, 2018, article on the Men's Health website entitled, "I Tried 3 CBD Supplements for Workout Recovery. Here's What Happened," discusses the benefits a reporter at the publication experienced using HempMeds® Real Scientific Hemp Oil™ (RSHO™) and HempMeds® Active Relief Roll-On. In an effort to help readers better understand why they should consider using these products, the article also explains what cannabidiol (CBD) is and how it interacts with your body. "We are excited to have this glowing testimonial for our CBD roll-on product, especially since we just announced our new 50-milligram version of it," said HempMeds® President Todd Morrow. "We trust this coverage will help us expand our reach and introduce consumers to the many wellness benefits of our products."

HEMP Inc. (OTCPK:HEMP) recently announced it is featured in an article by InvestorPlace ranking the company number 12 among the top 30 stocks to buy in the cannabis sector. InvestorPlace is an online publication that provides investors with specific, daily investing advice. The article highlights the huge potential for agricultural revenues from hemp and includes comments about Hemp, Inc.'s prospective growth as states continue to legalize hemp. The article, "30 Marijuana Stocks to Buy as the Future Turns Green," details the immense opportunity within the cannabis industry, highlighting the most promising investment opportunities. Though Hemp, Inc. is not a marijuana company but only deals with hemp, the editors decided to include it in the roundup due to the huge potential of the burgeoning hemp-derived cannabidiol (CBD) market. The article also highlights the changing public opinion on hemp, noting that the highly-conservative state of Oklahoma recently became the 37th to legalize industrial hemp production.

India Globalization Capital Inc. (NYSE:IGC) recently announced that it has filed a provisional method and composition patent application (IGC-509) with the U.S. Patent and Trademark Office (USPTO) for the treatment of fatigue and energy restoration. The filing is for a provisional patent and no assurance can be given as to whether or when a registered patent may be granted by the USPTO in the future. This patent filing made on October 4, 2018, is one of a series of steps in the Company's development and commercialization plan to support the creation of a branded, hemp/CBD sugar-free energy drink, which was previously disclosed by the Company on September 25, 2018.

The Supreme Cannabis Company Inc. (TSX-V:FIRE.V) (OTCQX:SPRWF) recently announced its 7Acres subsidiary has entered into a supply agreement with Tilray Inc. subsidiary Tilray Canada. Under the 12-month agreement starting Oct. 1, which is estimated to have a value of C$12 million ($9.3 million), 7Acres will provide dried cannabis to Tilray Canada to be used primarily to support medical cannabis patients in Canada. "We are happy to provide 7ACRES premium products alongside Tilray's well-regarded and existing lineup to support medical patients around the world," said Supreme Cannabis Chief Executive John Fowler. Supreme Cannabis shares have rallied 37% over the past three months, while the Horizons Marijuana Life Sciences Index ETF has climbed 31% and the S&P 500 has gained 7.1%.

DISCLAIMER:  FN Media Group LLC (FNM), which owns and operates Financialnewsmedia.com and MarketNewsUpdates.com, is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated in any manner with any company mentioned herein.  FNM and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNM's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release. FNM is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. For current services performed MNU has been compensated forty six hundred dollars for news coverage of the current press release issued by Marijuana Company of America, Inc. by the company. FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNM undertakes no obligation to update such statements.

Media Contact:  editor@financialnewsmedia.com  +1(561)325-8757

SOURCE FinancialNewsMedia.com



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store